instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Serious adverse event report Product A and Product B no current exposure
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Neurologist at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Serious adverse event report Product A and physician suspects both Product A and Ibuprofen
Dear Adverse Events Reporting Centre,
I am the Ward Nurse Manager at a Veterans Affairs medical centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a seriou... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected adverse reaction with suspect Product A with suspect Amoxicillin
Dear Drug Safety Department,
I am writing as the caregiver for my husband Nancy Jordan to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the trea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both med... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Safety report Product A and Levothyroxine excluded as causative agent
Hi,
I am the Consultant Gastroenterologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 41... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Serious adverse event report Product A and Amlodipine continued without change
Dear Patient Safety Team,
I am the Consultant Nephrologist at a pathology and diagnostics consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Pharmacovigilance report Product A with suspected Levothyroxine co-reaction
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects bot... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A adverse reaction with Methotrexate taken concurrently not suspected
Hi,
I am the Consultant Haematologist at a dialysis centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 41 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A suspected adverse reaction with previous Product B therapy
Dear Pharmacovigilance Team,
I am the Consultant Dermatologist at a hepatology referral centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Suspected adverse event with Product A and concomitant Amoxicillin therapy
Hi,
I am the Consultant Gastroenterologist at an immunology and allergy clinic and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 38 year... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A suspected adverse reaction with concurrent Product B use
Dear Regional Pharmacovigilance Lead,
I am the Clinical Nurse Specialist at a group of private outpatient clinics and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Urgent adverse event Product A and Amlodipine also suspected by physician
Dear Clinical Safety and Regulatory Affairs,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating phy... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse reaction with Product B stopped months ago
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 64 year old male patient on Product A for 1... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both medic... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with concomitant Product B exposure
To Whom It May Concern,
I am the Attending Physician at a private oncology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienc... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Formal adverse event notification Product A with continued Product B administration
Dear Drug Safety Department,
I am writing as the caregiver for my elderly aunt Stephanie Lane to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A adverse event and Product B past use excluded report
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 73 year old male patient started o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse event and ongoing Product B treatment report
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my sister Mary Green to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Serious adverse event report Product A and Product B ongoing without change
Hi,
I am the Clinical Pharmacy Director at a respiratory medicine centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Suspected adverse event with Product A and Product B implicated only as concomitant
Dear Pharmacovigilance Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 45 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Serious adverse event report Product A and Omeprazole excluded as causative agent
Dear Post-Marketing Surveillance Unit,
I am the Director of Clinical Services at a Veterans Affairs medical centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse reaction report involving Product A and suspected combined effect Product A and Amoxicillin
Dear Adverse Events Reporting Centre,
I am the Pharmacy Operations Manager at a pathology and diagnostics consortium and I am submitting this adverse event report on behalf of a patient who presented to our phar... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse event report Product A plus Product B stopped months ago
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my mother Nicole Nichols to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 37 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Adverse reaction report involving Product A and Product B not suspected
To Whom It May Concern,
I am the Consultant Rheumatologist at a rheumatology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A adverse event and suspect Product A with suspect Metformin report
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both medications as con... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Adverse reaction report involving Product A and ongoing Product B treatment
Good morning,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 41 year old female patient on Product A for 11 weeks... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Pharmacovigilance report Product A with historical Product B use
Hi,
I am the Senior Consultant at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 29 year old female patient st... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Urgent adverse event Product A and both Product A and Methotrexate identified as suspect
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my husband David Gomez to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event w... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Suspected adverse event with Product A and dual drug reaction Product A and Atorvastatin
Dear Patient Safety Team,
I am the Consultant Rheumatologist at a university hospital department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Serious adverse event report Product A and concomitant Product B exposure
Dear Sir or Madam,
I am writing as the caregiver for my wife Katherine Stevens to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 38 year old m... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Pharmacovigilance report Product A with Product B no current exposure
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 34 year old female patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Urgent adverse event Product A and dual drug reaction Product A and Amoxicillin
Dear Corporate Drug Safety Department,
I am the Head of Pharmacy Services at a womens health clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to repor... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Safety report Product A and Product B maintained during event
Dear Pharmacovigilance Team,
I am the Consultant Rheumatologist at a managed care organisation and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 59 y... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Safety report Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am the Consultant Endocrinologist at a specialist dermatology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating phys... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and dual drug reaction Product A and Levothyroxine
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the tre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Pharmacovigilance report Product A with Ibuprofen excluded as causative agent
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 34 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A suspected adverse reaction with historical Product B use
To Whom It May Concern,
I am the Senior Nurse Practitioner at a gastroenterology clinic partnership and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Suspected adverse event with Product A and Levothyroxine excluded as causative agent
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 50 year old female patient on Pr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A adverse reaction with suspected Ibuprofen co-reaction
Dear Medical Affairs and Drug Safety,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects b... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A reaction report with concurrent Product B use
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 76 year old female patient on Product A f... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse reaction report involving Product A and past Product B exposure
To Whom It May Concern,
I am writing as the caregiver for my father Emma Boyd to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 48 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Urgent adverse event Product A and Levothyroxine not implicated in adverse event
Dear Medical Affairs and Drug Safety,
I am the Consultant Pulmonologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Safety report Product A and Lisinopril excluded as causative agent
Dear Drug Safety Department,
I am the Consultant Cardiologist at a group of private outpatient clinics and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Formal adverse event notification Product A with Lisinopril stable during Product A reaction
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 58 year old... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A suspected reaction with Product B excluded as cause – formal report
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 73 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician susp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with ongoing Product B treatment
Dear Drug Safety Department,
I am the Consultant Nephrologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Good morning,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as contributory factors. Th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Pharmacovigilance report Product A with both Product A and Lisinopril identified as suspect
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my mother Kimberly Hunter to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse reaction with Amoxicillin concomitant medication only
Dear Post-Marketing Surveillance Unit,
I am the Clinical Pharmacist at a wound care centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse event report Product A plus Product B taken alongside
Dear Pharmacovigilance and Risk Management Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old female patient who ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Urgent adverse event Product A and both Product A and Atorvastatin identified as suspect
To Whom It May Concern,
I am the Consultant Neurologist at a gastroenterology clinic partnership and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Serious adverse event report Product A and Metformin concomitant medication only
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 55 year old female patient who was s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A suspected reaction with Levothyroxine stable during Product A reaction – formal report
Dear Regional Pharmacovigilance Lead,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 73 year... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Senior Consultant at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event wher... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A reaction and Amoxicillin taken concurrently not suspected formal notification
Dear Patient Safety Team,
I am the Consultant Hepatologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am the Consultant Cardiologist at a respiratory medicine centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am the Consultant Dermatologist at a pain management clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Safety report Product A and Product A and Ibuprofen jointly suspected
Dear Adverse Events Reporting Centre,
I am the Consultant Pulmonologist at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Serious adverse event report Product A and Product B unchanged during reaction
Dear Global Safety Unit,
I am the Director of Clinical Services at a Veterans Affairs medical centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Serious adverse event report Product A and Product B maintained during event
To Whom It May Concern,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 59 year old male patient on Product A for... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A suspected reaction with suspected Amlodipine co-reaction – formal report
To Whom It May Concern,
I am the Consultant Gastroenterologist at a tertiary referral hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Adverse event notification for Product A with Ibuprofen excluded as causative agent
Dear Post-Marketing Surveillance Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A adverse reaction with suspect Product A with suspect Levothyroxine
Dear Pharmacovigilance Team,
I am the Head of Pharmacy Services at a respiratory medicine centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
To Whom It May Concern,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects both medicati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A adverse event and suspect Product B also implicated report
Dear Regional Pharmacovigilance Lead,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A reaction report with Product B stopped before symptoms began
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 59 year old male patient on Product ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Safety report Product A and Product B no longer taken
Dear Sir or Madam,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 62 year old male patient initiated on Product A 8 weeks ago for an au... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Urgent adverse event Product A and Product B as background therapy
Dear Pharmacovigilance Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old female patient who was started on ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse reaction report involving Product A and Product B discontinued prior to event
Hi,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 59 year old male patient on Pro... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Pharmacovigilance report Product A with concomitant Product B exposure
Dear Clinical Safety and Regulatory Affairs,
I am the Clinical Nurse Specialist at a respiratory medicine centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Suspected adverse event with Product A and ongoing Product B treatment
Dear Drug Safety Department,
I am the Chief of Medicine at a university hospital department and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Product A adverse event and Amlodipine taken concurrently not suspected report
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old female patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Pharmacovigilance report Product A with dual drug reaction Product A and Omeprazole
Dear Medical Affairs and Drug Safety,
I am the Consultant Neurologist at a rural district hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse even... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Adverse event report Product A plus dual drug reaction Product A and Amlodipine
Dear Pharmacovigilance Team,
I am the Senior Consultant at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involving a patient under my ca... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Safety report Product A and Omeprazole concomitant medication only
Dear Clinical Safety and Regulatory Affairs,
I am the Clinical Nurse Specialist at a private cardiology practice group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A reaction and Methotrexate also suspected by physician formal notification
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my mother Catherine Rice to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A suspected adverse reaction with Product B past use excluded
Dear Sir or Madam,
I am the Clinical Pharmacist at a regional hospital trust and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A reaction report with Lisinopril excluded as causative agent
Dear Adverse Events Reporting Centre,
I am the Consultant Endocrinologist at a private oncology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction report with Amoxicillin also suspected by physician
To Whom It May Concern,
I am writing as the caregiver for my elderly aunt Jerry Jimenez to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physicia... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Suspected adverse event with Product A and continued Product B administration
Dear Global Safety Unit,
I am the Chief of Medicine at a home healthcare nursing agency and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing as the caregiver for my sister Frank Morgan to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physici... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse event report Product A plus concomitant Product B exposure
Dear Global Safety Unit,
I am the Consultant Dermatologist at a corporate occupational health provider and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient exper... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am the Medical Director at a rheumatology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event whe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Adverse reaction report involving Product A and Product B maintained during event
Dear Corporate Drug Safety Department,
I am the Consultant Endocrinologist at an immunology and allergy clinic and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse e... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse event notification for Product A with Ibuprofen maintained as background medication
Dear Global Safety Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 67 year old female patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected adverse reaction with physician suspects both Product A and Amoxicillin
Dear Corporate Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Urgent adverse event Product A and Product B as background therapy
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my father Kevin Morris to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 53 y... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Serious adverse event report Product A and Product B as background therapy
Dear Patient Safety Team,
I am the Clinical Pharmacy Director at a corporate occupational health provider and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Urgent adverse event Product A and concomitant Methotrexate therapy
Dear Clinical Safety and Regulatory Affairs,
I am the Senior Nurse Practitioner at a faith-based hospital system and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse event report Product A plus Metformin excluded as causative agent
Dear Regional Pharmacovigilance Lead,
I am the Senior Consultant at a home healthcare nursing agency and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Patient Safety Team,
I am writing as the caregiver for my elderly aunt Jonathan Stewart to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physicia... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A reaction report with Product B completed course before reaction
Dear Patient Safety Team,
I am writing as the caregiver for my wife Rebecca Owens to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 42 year ol... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A suspected adverse reaction with Product B prior use not relevant
Dear Corporate Drug Safety Department,
I am the Consultant Neurologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 58 year old male patient on Product A for 18 weeks who developed new-onset atrial fibrillation with rapid ventricular response, palpitations, and dyspnoea requiring electr... |
SUBJECT: Adverse event report Product A plus ongoing Product B treatment
Dear Sir or Madam,
I am writing as the caregiver for my wife Richard Kelly to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 67 year old female patient ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected adverse reaction with suspect Product B also implicated
Dear Patient Safety Team,
I am writing as the caregiver for my elderly aunt Steven Harrison to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse event and Product B stopped before symptoms began report
Dear Sir or Madam,
I am the Consultant Rheumatologist at a large academic medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Suspected adverse event with Product A and Product B implicated only as concomitant
Good morning,
I am the Clinical Nurse Specialist at a tertiary referral hospital and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Urgent adverse event Product A and Omeprazole taken concurrently not suspected
Dear Sir or Madam,
I am the Consultant Endocrinologist at a surgical day case unit group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.